Combined Medication of Antiretroviral Drugs Tenofovir Disoproxil Fumarate, Emtricitabine, and Raltegravir Reduces Neural Progenitor Cell Proliferation In Vivo and In Vitro

The application of combination antiretroviral therapy has greatly reduced the death rate from AIDS. However, up to 50% of patients on combination antiretroviral therapy develop HIV-associated neurocognitive disorders (HAND), which is associated with residual neuroinflammation and oxidative injury in...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Peipei, Wang, Yingchun, Qin, Zhao, Qiu, Lisha, Zhang, Min, Huang, Yunlong, Zheng, Jialin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693968/
https://www.ncbi.nlm.nih.gov/pubmed/28735382
http://dx.doi.org/10.1007/s11481-017-9755-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693968/
https://www.ncbi.nlm.nih.gov/pubmed/28735382
http://dx.doi.org/10.1007/s11481-017-9755-4

Ejemplares similares